Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$10.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | DTOISS◆ | 225,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 225,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | DTOISS◆ | 249,999 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 249,999 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 224,500 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | ANTX | AN2 Therapeutics, Inc. | AGRANT | 112,250 | — | — | +43.8% | Open the original filing on SEC.gov |
| Jun 2, 2025 | ANTX | AN2 Therapeutics, Inc. | PBUY | 10,000 | $1.07 | $10.7K | +4.1% | Open the original filing on SEC.gov |